Screener
Charles River Laboratories CRL Other, net
Other, net at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|
| Purchase of treasury stock | (323,881) | (360,484) |
| Payments of contingent consideration | (11,400) | (21,822) |
| Purchase of remaining equity interests of other redeemable noncontrolling interest | — | (19,140) |
| Other, net | (2,607) | (6,458) |
| Net cash provided by (used in) financing activities | 183,063 | (332,246) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 467 | 17,934 |
| Net change in cash, cash equivalents, and restricted cash | 24,584 | (20,830) |
| Cash, cash equivalents, and restricted cash, beginning of period | 215,997 | 205,570 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's other, net?
- Charles River Laboratories (CRL) reported other, net of -$607K in Q2 2026.
- How has Charles River Laboratories's other, net changed year-over-year?
- Charles River Laboratories's other, net increased by 90.6% year-over-year, from -$6.46M to -$607K.
- What does other, net mean?
- Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.
Ask your AI about Charles River Laboratories's other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude